Pelvic Floor Magnetic Stimulation in Women With Idiopathic Overactive Bladder

  • STATUS
    Recruiting
  • participants needed
    76
  • sponsor
    Pamukkale University
Updated on 19 February 2024

Summary

In clinical practice, Bladder Traininhg (BT) and Magnetic stimulation (MS) are frequently used together in the treatment of women with idiopathic overactive bladder (OAB). Up to our knowledge, there is no study evaluating the combined effect of magnetic stimulation and bladder training in women with idiopathic OAB in the literature. Moreover, there is no recommendation on conservative treament combinations in the guidelines due to insufficient data. At this stage, studies are needed to determine whether it will be effective to use MS in combination with other conservative treatment options. In addition, in the light of our clinical experience, we think that this issue is still open for research. In our study, adding MS to BT in women with idiopathic AAM is thought to contribute additionally to the efficacy of treatment with BT.

Our study is the first prospective randomized controlled trial that compares the efficacy of BT and BT plus MS in women with idiopathic OAB. In this study, we aimed to evaluate the efficacy of MS added to BT on incontinence-related QoL and clinical parameters in women with idiopathic OAB.

Description

This study is a prospectively randomized, controlled trial. The trial is held at Urogynecological Rehabilitation Unit of XXXX, Physical Medicine and Rehabilitation Department between September 2020 and November 2021. The local ethics committee approve the study (approvel no: 60116787-020/37878). Patients are informed about the purpose and contents of the study and all women give written consent to participate.

By using a random number generator, all patients which included the study were randomized into two groups as follows: The Group 1 received BT program alone, the Group 2 received BT plus MS.

Group 1: Bladder Training (BT) - Control group All women were informed about BT for 30 minutes. Then it was given as a written brochure to be implemented as a home program.

BT, consisting of four stages, did not contain any PFMT programs in two groups.

Group 2: BT plus MS Patients are told to sit on the chair with a magnetic coil below the chair. When a volume conductor is in serted by this magnetic eld, an eddy current ow is generated. This eddy current stimulates nerve or muscle of the pelvic oor. To apply MS, the device was set to generate its maximum stimuli, with a stimulation pulse width of 200 s and a stimulation repetition cycle of 10 Hz in accordance with the literature (10,13-15). When setting the device at each treatment session, patients were interviewed so that they received stimuli at the maximum stimulation intensity (maximum tolerable stimulation intensity) (10). MS was applied two days a week, 20 minutes a day, a total of 12 sessions for 6 weeks. MS sessions were performed by other physician.

Details
Condition Reduction of Urge Incontinence Episodes After the Magnetic Stimulation Added to Bladder Training in Women With Idiopathic Overactive Bladder
Age 18years - 100years
Treatment Magnetic stimulation -Armchair type (MS), Bladder Training (BT)
Clinical Study IdentifierNCT04450511
SponsorPamukkale University
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Women over the age of 18 with clinical diagnosis of idiopathic OAB
Urodynamically conrmed detrusor overactivity (the presence of detrusor
contractions in the lling phase of saline cystometry) Not tolerated or
unresponsive to antimuscarinics and discontinued at least 4 weeks Able to give
written, informed consent Able to understand the precedures, advantages and
possible side effects Willing and able to complate the voiding diary and QoL
questionnaire The strength of PFM 3/5 and more

Exclusion Criteria

History of BT, MS therapy Pregnancy or intention to become pregnant during the
study Current vulvovaginitis or urinary tract infections or malignancy More
than stage 2 according to the pelvic organ prolapse quantification (POP-Q)
Cardiac pacemaker, implanted defibrillator, coronary artery stent Ongoing
treatment for arrhythmia Lower abdominal pain or dysmenorrhea yet to be
diagnosed Electronic device or metallic implant applied to areas between the
lumbar region and lower extremities Previous urogyneceological surgery within
months Ongoing surgical treatment or treatment with implantable devices for
urinary incontinence or use of intrauterin copper devices Neurogenic bladder
signs of neurologic abnormalities at objective examination; history of the
peripheral or central neurologic pathology Ultrasonographic evidence of PVR
volume more than 100 ml
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study AnnotationsStudy Notes

Notes added here are public and can be viewed by anyone. Notes added here are only available to you and those who you share with.

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.